|
Volumn 232, Issue 1-2, 2002, Pages 149-156
|
In vitro and in vivo aspects of quantifying intrapulmonary deposition of a dry powder radioaerosol
|
Author keywords
Administration, inhalation; Gamma scintigraphy; Powder inhaler; Radioactive aerosol; Radionuclide imaging; Technetium 99m
|
Indexed keywords
LACTOSE TECHNETIUM TC 99M;
RADIOISOTOPE;
RADIOPHARMACEUTICAL AGENT;
TECHNETIUM 99M;
UNCLASSIFIED DRUG;
ADULT;
AEROSOL;
AIRWAY;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DENSITY;
DRUG DELIVERY SYSTEM;
DRUG DISTRIBUTION;
DRUG FORMULATION;
DRUG PENETRATION;
DRY POWDER;
GAMMA SCINTIGRAPHY;
HUMAN;
INHALATION;
INSPIRATORY CAPACITY;
MALE;
NORMAL HUMAN;
PRIORITY JOURNAL;
RADIOACTIVITY;
RANDOMIZED CONTROLLED TRIAL;
SUSPENSION;
ADMINISTRATION, INHALATION;
ADULT;
ANALYSIS OF VARIANCE;
CROSS-OVER STUDIES;
HUMANS;
LACTOSE;
LUNG;
MALE;
POWDERS;
TECHNETIUM;
TISSUE DISTRIBUTION;
|
EID: 0037203699
PISSN: 03785173
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-5173(01)00898-5 Document Type: Article |
Times cited : (11)
|
References (22)
|